Ww International, INC 8-K filings

WW International, Inc. reported the voting results from its 2026 annual meeting of shareholders, including the election of directors and ratification of its auditor.

WW International announced its first quarter 2026 financial results, highlighting growth in its Clinical segment and reaffirming full-year guidance, while also detailing debt reduction efforts.

WW International announces plans to use up to $40 million in cash to reduce its outstanding term loan principal, comprising an annual cash sweep and a discounted voluntary prepayment.

WW International, Inc. announced the appointment of Heather Thiltgen to its Board of Directors, effective April 20, 2026, to enhance its integrated weight health strategy.

WW International director Michael Mason has resigned, and the company has finalized compensation terms for its interim executive office.

WW International announces committee assignments for newly appointed directors Lisa Gavales and Sue Gove, reinforcing leadership structure.

WW International appoints Lisa Gavales and Sue Gove as independent directors to bolster its digital transformation and operational oversight.

WW International announced the resignation of its CEO, Tara Comonte, effective March 31, 2026, with an interim Office of the CEO established and a search for a permanent successor underway.

WW International, Inc. announced strong fourth-quarter and full-year 2025 results, exceeding guidance, driven by significant growth in its Clinical business despite headwinds in its traditional Behavioral segment.

WW International's Board and Compensation Committee approved new performance-based equity and cash awards for executives and an increased base salary for its CFO.

WeightWatchers reported strong clinical revenue growth and a significantly strengthened balance sheet in Q3 2025, despite a decline in total subscribers and overall revenue.

WW International, Inc. has amended its consulting agreement with former Chief Product Officer Donna Boyer, extending her services to ensure a smooth transition until September 30, 2025, with aggregate compensation of $143,720.

WW International, Inc. announced its second quarter 2025 results, highlighting the successful completion of its financial reorganization, a $1.15 billion debt reduction, and a strategic shift towards clinical weight management despite overall revenue and subscriber declines.

WW International, Inc. announced the successful completion of its strategic financial reorganization, significant leadership appointments, and a new program focused on women's perimenopause and menopause health.

WW International, Inc. has successfully emerged from Chapter 11 bankruptcy, implementing a prepackaged reorganization plan that significantly reduces its debt and establishes a new capital and governance framework.

WW International, Inc. (WeightWatchers) announced its prepackaged Chapter 11 plan of reorganization has been confirmed by the court, paving the way for a significant debt reduction and emergence from bankruptcy as early as next week.

WW International, Inc. has been delisted from Nasdaq and is undergoing a prepackaged Chapter 11 bankruptcy to significantly reduce its debt, while shareholders voted on director elections and executive compensation.

WW International, Inc. (WW) has announced its delisting from Nasdaq and subsequent trading on the OTC Pink Current Market, alongside an amendment to its prepackaged Chapter 11 reorganization plan that modifies the terms of its takeback debt.

WW International (Weight Watchers) receives notice of delisting from Nasdaq following the commencement of voluntary prepackaged Chapter 11 cases.

WW International, Inc. initiates a pre-packaged Chapter 11 reorganization to eliminate $1.15 billion in debt and enhance its financial flexibility.

WW International reports a 9.7% revenue decrease in Q1 2025, but sees a 57.1% increase in clinical subscription revenues and is engaged in discussions for a plan of reorganization to significantly reduce debt.

WW International (WeightWatchers) received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, putting its listing at risk.

WW International reports a decrease in overall subscribers and revenue for Q4 and full year 2024, but sees growth in its clinical subscription business and improved margins.

WW International draws down the remaining available amount under its senior secured revolving credit facility to enhance financial flexibility.

WW International, Inc. has announced a change in its financial leadership, with Heather Stark stepping down as CFO and Felicia DellaFortuna appointed as her successor.

WW International's Q3 2024 results show a decline in overall subscribers and revenue, but a significant increase in clinical subscribers and improved adjusted gross margin.

WeightWatchers CEO Sima Sistani has stepped down, with board member Tara Comonte appointed as interim CEO, effective September 27, 2024.

WW International reported a decrease in revenue and subscribers for Q2 2024, while also announcing a restructuring plan aimed at cost savings and operational streamlining.

WW International has amended its previous 8-K filing to correct voting results from its annual shareholder meeting and to reflect changes to its Articles of Incorporation.

WW International's Chief Marketing Officer, Amanda Tolleson, will depart the company on June 4, 2024, with a separation agreement including a year of salary continuation and health benefits.